27 related articles for article (PubMed ID: 9192833)
1. Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma.
Yu T; Xu-Monette ZY; Yu L; Li Y; Young KH
Cell Death Dis; 2023 Nov; 14(11):771. PubMed ID: 38007476
[TBL] [Abstract][Full Text] [Related]
2. P53: A Key Target in the Development of Osteoarthritis.
Ma W; Tan X; Xie Z; Yu J; Li P; Lin X; Ouyang S; Liu Z; Hou Q; Xie N; Peng T; Li L; Dai Z; Chen X; Xie W
Mol Biotechnol; 2024 Jan; 66(1):1-10. PubMed ID: 37154864
[TBL] [Abstract][Full Text] [Related]
3. Wild-type
Zhang C; Martinez-Ledesma E; Gao F; Zhang W; Ding J; Wu S; Li X; Wu J; Yuan Y; Koul D; Alfred Yung WK
Am J Cancer Res; 2019; 9(8):1734-1745. PubMed ID: 31497354
[TBL] [Abstract][Full Text] [Related]
4. EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
Fitzsimmons L; Kelly GL
Viruses; 2017 Nov; 9(11):. PubMed ID: 29137176
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor potentiates chemotherapy-induced apoptosis through Bim upregulation in Burkitt's lymphoma cells.
Dos Santos Ferreira AC; Fernandes RA; Kwee JK; Klumb CE
J Cancer Res Clin Oncol; 2012 Feb; 138(2):317-25. PubMed ID: 22131152
[TBL] [Abstract][Full Text] [Related]
6. Rac1 targeting suppresses p53 deficiency-mediated lymphomagenesis.
Bosco EE; Ni W; Wang L; Guo F; Johnson JF; Zheng Y
Blood; 2010 Apr; 115(16):3320-8. PubMed ID: 20179179
[TBL] [Abstract][Full Text] [Related]
7. How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
Allday MJ
Semin Cancer Biol; 2009 Dec; 19(6):366-76. PubMed ID: 19635566
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus and Burkitt lymphoma.
Brady G; MacArthur GJ; Farrell PJ
J Clin Pathol; 2007 Dec; 60(12):1397-402. PubMed ID: 18042696
[TBL] [Abstract][Full Text] [Related]
9. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas.
Hoyer KK; Pang M; Gui D; Shintaku IP; Kuwabara I; Liu FT; Said JW; Baum LG; Teitell MA
Am J Pathol; 2004 Mar; 164(3):893-902. PubMed ID: 14982843
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents.
Lin Z; Lim S; Viani MA; Sapp M; Lim MS
Am J Pathol; 2001 Aug; 159(2):711-9. PubMed ID: 11485929
[TBL] [Abstract][Full Text] [Related]
11. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth.
Pike SE; Yao L; Jones KD; Cherney B; Appella E; Sakaguchi K; Nakhasi H; Teruya-Feldstein J; Wirth P; Gupta G; Tosato G
J Exp Med; 1998 Dec; 188(12):2349-56. PubMed ID: 9858521
[TBL] [Abstract][Full Text] [Related]
12. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53.
Ramqvist T; Magnusson KP; Wang Y; Szekely L; Klein G; Wiman KG
Oncogene; 1993 Jun; 8(6):1495-500. PubMed ID: 8502475
[TBL] [Abstract][Full Text] [Related]
13. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control.
Pollock R; Lang A; Ge T; Sun D; Tan M; Yu D
Clin Cancer Res; 1998 Aug; 4(8):1985-94. PubMed ID: 9717829
[TBL] [Abstract][Full Text] [Related]
14. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
15. [P53 genes and malignant hematologic diseases].
Jonveaux P
Bull Cancer; 1993 Aug; 80(8):697-703. PubMed ID: 8204951
[TBL] [Abstract][Full Text] [Related]
16. Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells.
Cherney BW; Bhatia KG; Sgadari C; Gutierrez MI; Mostowski H; Pike SE; Gupta G; Magrath IT; Tosato G
Cancer Res; 1997 Jun; 57(12):2508-15. PubMed ID: 9192833
[TBL] [Abstract][Full Text] [Related]
17. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines.
O'Connor PM; Jackman J; Jondle D; Bhatia K; Magrath I; Kohn KW
Cancer Res; 1993 Oct; 53(20):4776-80. PubMed ID: 8402660
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
